{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-061639","form_type":"8-K","ticker":"ALLR","cik":"0001860657","company_name":"Allarity Therapeutics, Inc.","filed_at":"2025-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.417374+00:00","generated_at":"2026-05-18T09:20:51.979490+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Allarity Therapeutics CFO resigns; appoints Jeffrey Ervin as part-time CFO effective July 1, 2025","bullets":["CFO Alexander Epshinsky resigned June 30, 2025; not due to any disagreement with the company.","Jeffrey S. Ervin appointed part-time CFO on July 1, 2025; annual base salary of $175,000.","Ervin previously served as fractional co-CFO of DDC Enterprise (NYSE: DDC) and chairman/CEO of IMAC Holdings (Nasdaq: BACK).","Ervin also serves as independent director of Cingulate, Inc. (Nasdaq: CING); holds MBA from Vanderbilt.","Severance: 6 months' base salary if terminated after Change-of-Control, subject to signed release."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-061639","json":"https://secwatch.observer/filing/0001213900-25-061639.json","markdown":"https://secwatch.observer/filing/0001213900-25-061639.md","text":"https://secwatch.observer/filing/0001213900-25-061639.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860657/000121390025061639/0001213900-25-061639-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860657/000121390025061639/ea0248238-8k_allarity.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:20:51.979490+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}